Cosmo Presents Agenda for AGM 2026

Dublin, Ireland--(Newsfile Corp. - March 12, 2026) - Cosmo Pharmaceuticals N.V. (Cosmo) is pleased to announce the convening of its upcoming Ordinary Annual General Meeting of Shareholders (AGM) to be held on 10 April 2026 in Amsterdam.

The agenda includes, among others, the following discussion and voting items:

• Report of the Board of Directors on the business year 2025 and the ESG achievements
• Appropriation of the Full-Year 2025 results
• Proposal to grant discharge to the members of the Board of Directors
• Proposal to adopt the proposed resolution of the Board of Directors to declare a distribution out of the Companys freely distributable reserves (of EUR 2.10 per share)
• Proposal to amend the Articles of Association of Cosmo and change its name to Cosmo N.V.
• Proposal to adopt the Company's remuneration policy
• Proposal to reappoint the members of the Board of Directors standing for re-election for a period of one year
• Three proposals to authorise the Board of Directors to issue and/or grant rights to subscribe for ordinary shares and preferred shares

The convening notice with the complete AGM agenda items, the explanatory notes and the written proxy are all available on the Companys website via www.cosmohealthconfidence.com/agm. Cosmos Annual Report 2025 and ESG Report 2025 can be found here: www.cosmohealthconfidence.com/key-financial-reports.

About Cosmo
Cosmo is a life sciences company focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). We design, develop, and manufacture advanced solutions that address critical medical needs and raise the standard of care. Our technologies are trusted by leading global pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. Guided by our purpose - Building Health Confidence - our mission is to empower patients, healthcare professionals, and partners by innovating at the intersection of science and technology. Founded in 1997, Cosmo is headquartered in Dublin, Ireland, with offices in San Diego (USA), and in Lainate, Rome, and Catania (Italy). For more information, visitwww.cosmohealthconfidence.com.

Attachments
PDF - English

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/288242

You May Also Be Interested In

• Lions Clubs International Announces Mark S. Lyon as 2026-2027 International President
• ShapedBae Expands Its Personalized Wellness Ecosystem Under CEO London Greer's Vision
• Coloured Ties Capital Announces Proposed Share Consolidation